Archive for the ‘United States’ Category
Emergent BioSolutions to Acquire Trubion Pharmaceuticals
Trubion provides promising clinical-stage therapeutic candidates in the targeted disease areas of oncology and autoimmunity
Trubion offers novel, protein therapeutic platforms and scientific expertise for developing innovative therapeutic candidates
Transaction leverages large pharma partnerships to provide sales and marketing infrastructureidates
Emergent reaffirms 2010 guidance for revenues and net income
ROCKVILLE, Md., Aug 12, 2010 (BUSINESS WIRE) –
Emergent BioSolutions Inc. [...]
In: Chief Exeutive Officer, Emergent Bioslutions, Fuad El-Hibri, Shareholder, Trubion Pharmaceuticals, United States · Tagged with: Biosolutions, Board of directors, Common stock, Emergent BioSolutions, Seattle, Stock, Systemic Lupus Erythematosus, Trubion Pharmaceuticals
Emergent BioSolutions Hosts Biopreparedness Roundtable for NATO Parliamentarians
ROCKVILLE, Md., Jul 12, 2010 (BUSINESS WIRE) –
Emergent BioSolutions Inc. (NYSE:EBS) is hosting “Bioterrorism Prevention, Preparedness and Response,” a forum organized for members of the North Atlantic Treaty Organization (NATO) Parliamentary Assembly (PA) to raise global awareness of the importance of biopreparedness. The visiting delegation [...]
In: Biothrax, Chief Exeutive Officer, Emergent Bioslutions, Fuad El-Hibri, U.S. Food and Drug Administration, United States, Washington · Tagged with: Anthrax vaccines, Emergent BioSolutions, Food and Drug Administration, NATO, United States, United States Department of Health and Human Services
Fuad El-Hibri and Healthcare Reform
Fuad El-Hibri serves on the Advisory Board for the Yale Healthcare Conference, a joint effort between the Yale School of Management and the Health Professional Schools at Yale University. The 6th annual healthcare conference was held on April 9, 2010 in New Haven, CT. The conference topic was “Re-Forming Healthcare: Excellence in a Transforming [...]
In: Emergent Bioslutions, United States, Yale university · Tagged with: Colleges and Universities, Emergent BioSolutions, Fuad El-Hibri, Health care, United States, Yale university
Emergent BioSolutions Chairman and CEO Fuad El-Hibri Recognized as Outstanding International Business Leader
ROCKVILLE, Md., Mar 11, 2010 (BUSINESS WIRE) — Emergent BioSolutions Inc. (EBS 15.96, -0.03, -0.19%) announced today that Fuad El-Hibri, its chairman and chief executive officer, has been named by the World Trade Center Institute (WTCI) as one of Maryland’s outstanding international business leaders. Celebrating the spirit of global ambition and excellence in international leadership, [...]
In: Business, Chief Exeutive Officer, Emergent Bioslutions, Fuad El-Hibri, United States · Tagged with: Business, Emergent BioSolutions, Fuad El-Hibri, Maryland
500 Most Influential Muslims: Science and Technology
The Prince Alwaleed Bin Talaal Center for Muslim-Christian Understanding and The Royal Islamic Strategic Studies Centre published its first edition in what promises to be an annual series of insight into the movers and shakers of the Muslim world. Entitled The 500 Most Influential Muslims 2009, the book categorizes Muslims’ influential capacities into 15 [...]
In: Chief Exeutive Officer, Emergent Bioslutions, Fuad El-Hibri, United States, Washington D.C · Tagged with: biopharmaceutical company, Emergent BioSolutions, Fuad El-Hibri, muslims
Emergent BioSolutions Inc., Q2 2009 Earnings Call Transcript
Emergent BioSolutions Inc., (EBS)
Q2 2009 Earnings Call
August 6, 2009 5:00 pm ET
Executives
Robert G. Burrows – Vice President, Investor Relations
Fuad El-Hibri – Chairman of the Board, Chief Executive Officer
R. Don Elsey – Chief Financial Officer
Daniel J. Abdun-Nabi – President, Chief Operating Officer
W. James Jackson, Ph.D. – Senior Vice President and Chief Scientific Officer
Analysts
Eric Schmidt [...]
In: Chief Exeutive Officer, Emergent Bioslutions, Fuad, Fuad El-Hibri, Shareholder, United States · Tagged with: Chairman, Chief executive officer, Chief financial officer, Chief operating officer, finance, Investor relations, United States, Vice president
Emergent BioSolutions Inc. (EBS) CEO & Chairman, 10% Owner Fuad El-hibri sells 15,000 Shares
CEO & Chairman, 10% Owner of Emergent BioSolutions Inc. (EBS) Fuad El-hibri sells 15,000 shares of EBS on 08/11/2009 at an average price of $16.78 a share.
EMERGENT BIOSULUTIONS INC. is a leading biopharmaceutical company dedicated to one simple mission – to protect life. EBS develops manufactures and commercializes vaccines and therapeutics that assist the body\’s [...]
In: Chief Exeutive Officer, Emergent Bioslutions, Fuad, Fuad El-Hibri, Shareholder, United States, Washington D.C · Tagged with: Anthrax, Anthrax vaccines, Emergent BioSolutions, Health, Infectious disease, Public health, U.S. Food and Drug Administration, Vaccine
Rene Moawad Foundation (RMF) USA Holds 14th Annual Washington Gala Dinner
Honors Partnership for Lebanon & Mr. Fuad El-Hibri
Features Lebanese Fashion Designer Jean Fares
The Rene Moawad Foundation, USA will hold its 14th Annual Benefit Gala on Saturday, October 20, 2007 at the Ritz Carlton Hotel in Pentagon City , VA. Since its creation in 1993, RMF-USA has succeeded in assembling a large [...]
In: Chief Exeutive Officer, Emergent Bioslutions, Fuad, Fuad El-Hibri, Lebanon, Rene Moawad Foundation, United States · Tagged with: Government, Guides and Directories, Houston, Lebanon, Miami, Middle East, Society and Culture, United States
Emergent BioSolutions moves forward with typhoid vaccine
Emergent BioSolutions is on the path to finding gold with its typhoid vaccine following positive results in a Phase II trial.
The Maryland-based biopharmaceutical company is developing a single-dose oral drinkable typhoid vaccine aimed to take on Crucell’s three to four dose oral formulation and Sanofi’s injectable formulation. The global travellers market was worth $130m (€92m) [...]
In: Chief Exeutive Officer, Clinical trial, Emergent Bioslutions, Fuad, Fuad El-Hibri, United States · Tagged with: Clinical trial, Conditions and Diseases, Crucell, Health, Immune system, Infectious disease, Sanofi-Aventis, Vaccination
Fuad El-Hibri on Wikipedia
Early Life
Fuad El-Hibri (born March 2, 1958) in Hildesheim, Germany[1] spent his childhood equally in Europe and the Middle East before coming to the USA to get an economics degree from Stanford and an MBA from Yale[1]
Education
Mr.El-Hibri earned a Masters Degree in Public and Private Management from Yale University and a Bachelors Degree with [...]
In: Chief Exeutive Officer, Emergent Bioslutions, Fuad, Fuad El-Hibri, Social Network, United States, Yale university · Tagged with: Booz Allen Hamilton, Jeddah, Mergers and acquisitions, Middle East, Saudi Arabia, Stanford University, United States, Yale university